In conclusion, our study provides new evidence that GPR43 can improve mitochondrial function, reduce neuronal and synaptic damage, and inhibit apoptosis by inhibiting CypD activity, thereby improving cognitive and learning dysfunction in AD mice. This evidence concerns the gene FFAR2 and Alzheimer disease.